CN103735778B - A kind of Chinese medicine composition for the treatment of of obesity - Google Patents
A kind of Chinese medicine composition for the treatment of of obesity Download PDFInfo
- Publication number
- CN103735778B CN103735778B CN201410007923.XA CN201410007923A CN103735778B CN 103735778 B CN103735778 B CN 103735778B CN 201410007923 A CN201410007923 A CN 201410007923A CN 103735778 B CN103735778 B CN 103735778B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- parts
- obesity
- chinese medicine
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 208000008589 Obesity Diseases 0.000 title claims abstract description 31
- 235000020824 obesity Nutrition 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 17
- 239000010271 massa medicata fermentata Substances 0.000 claims abstract description 17
- 241000628997 Flos Species 0.000 claims description 11
- 241001247821 Ziziphus Species 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 22
- 210000000952 spleen Anatomy 0.000 abstract description 19
- 229940079593 drug Drugs 0.000 abstract description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 13
- 208000026435 phlegm Diseases 0.000 abstract description 13
- 230000001105 regulatory effect Effects 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract description 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000207783 Ipomoea Species 0.000 description 1
- 240000007218 Ipomoea hederacea Species 0.000 description 1
- 241000207890 Ipomoea purpurea Species 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for the treatment of of obesity, it is characterized in that the crude drug comprising following weight portion: Poria 8-12 part, Rhizoma Pinelliae 8-15 part, Rhizoma Atractylodis 8-12 part, Rhizoma Cyperi 8-12 part, Pericarpium Citri Reticulatae 2-5 part, Massa Medicata Fermentata 8-15 part, Rhizoma Chuanxiong 8-12 part, Semen Pharbitidis 1-3 part.Pharmaceutical formulation science of the present invention, taking convenience, good absorbing, side effect is little, has invigorating the spleen for dissipating phlegm, effect of resolving depression of regulating the flow of vital energy, blood circulation promoting and blood stasis dispelling, can quick weight-lossing, rapid-action to obesity, without bounce-back, stable curative effect, definite.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of quick weight-lossing treatment of obesity, belong to technical field of Chinese medicines.
Background technology
Obesity (adiposity) is because excessive fat stores makes body weight exceed the overnutrition disease of normal more than 20%, has simple obesity and secondary obesity two class.Adult Body Mass Index (body mass index, BMI) for body weight (kg) divided by height (m) square, be assessment obese degree index.Body Mass Index is greater than 30 and is called obesity.Can the person of seeking simple obesity be claimed without the obvious cause of disease; There is clear and definite cause of disease person and be called secondary obesity.Simple Obesity, may be relevant with the factor such as heredity, diet and motor habit without the clear and definite cause of disease.Medically also it is called that constitutional is fat, in all obesities, more than 99% is Simple Obesity so long.Secondary Obesity accounts for fat ratio and is only 1%, and spininess is treated the cause of disease.
The Etiological Most scholars of simple obesity is thought caused by the life style (hypomotility) of excessive Energy intaking and silent oscillation; A few peoples think, food Excess free enthalpy is hereditary with family, physiology is relevant with mental illness, individual bad living habit etc.Generally speaking, the Excess free enthalpy of energy is greater than consumption is the fat origin cause of formation.
Modern medicine thinks that Simple Obesity is many with endocrine regulation, various hormone, and especially insulin, gonadal hormone, adrenocortical hormone, leptin etc. are abnormal, but the few curative effect of targeted drug is fast, easily bounce-back and side effect is large, can not effect a permanent cure.And it is relevant to analyze the fat main function dirty with liver,spleen,kidney three according to the organic conception of theory of Chinese medical science from the differentiation of disease according to pathological changes of the viscera and their, deficiency of spleen-QI, can not normal metaplastic essence and blood, and defeated cloth is precise and tiny, the whole body of supplementing nutrition, and becomes cream fat phlegm-damp, stores in skin, sends out as obesity.Deficiency of kidney-QI, can not normal promote the circulation of qi and water, helps spleen health movement, regulating fluid apssage and turbid damp is cohesion, overflows in skin and increases the weight of obesity.Damaged by excess of seven emotions, often causes irritability stasis, and it is smooth that suffocating of liver and gall is lost in tune, affects the strong fortune of spleen, and the lifting of mechanism of qi is transferred.And gallbladder normally can not secrete semen deposition juice, clean turbidity fat, then turbid fat is cohesion and fat.Due to spleen deficiency of kidney-QI, liver and gall are lacked of proper care, and not only cause cream fat expectorant turbid, and water is wet to stop storing, and also make mechanism of qi lose smooth, sering is unfavorable, can have the stagnation of QI, or blood stasis.Therefore, overweight people's existing deficiency syndrome, have again mark excess syndrome, deficiency in origin and excess in superficiality connects each other, simultaneously and deposit.In a word, sick position based on spleen, secondary and kidney and liver and gall, also can and cardiopulmonary, but be always common with spleen deficiency of kidney-QI, suffocating of liver and gall imbalance also shows.Cure the disease and must ask it, catch deficiency in origin and excess in superficiality, deficiency in origin is based on the deficiency of vital energy, and mark reality is turbid based on cream fat, expectorant; The spleen being the source of producing phlegm again, treats with invigorating the spleen for dissipating phlegm, and dampness removing purging FU-organs is general provisions.Conditioning viscera can be reached by Chinese medicine reasonable compatibility, make the functional rehabilitation of liver,spleen,kidney normal, by regulating dietary structure, preventing extraneous fat intake surplus, improving health environment, allow health itself possess and consume the ability of superabundant fats, this is only the most fundamental way for the treatment of of obesity.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of of obesity, each organ function of this medicine energy conditioning human body, fundamentally root out the fat cause of disease, the effect play treating both the principal and secondary aspects of a disease, not rebounding.
The present invention is achieved by the following technical solutions:
A Chinese medicine composition for treatment of obesity, is characterized in that the crude drug comprising following weight portion: Poria 8-12 part, Rhizoma Pinelliae 8-15 part, Rhizoma Atractylodis 8-12 part, Rhizoma Cyperi 8-12 part, Pericarpium Citri Reticulatae 2-5 part, Massa Medicata Fermentata 8-15 part, Rhizoma Chuanxiong 8-12 part, Semen Pharbitidis 1-3 part.
Above-mentioned Chinese medicine composition, preferably includes the crude drug of following weight portion: 10 parts, Poria, the Rhizoma Pinelliae 10 parts, Rhizoma Atractylodis 10 parts, Rhizoma Cyperi 10 parts, Pericarpium Citri Reticulatae 3 parts, Massa Medicata Fermentata 10 parts, Rhizoma Chuanxiong 10 parts, Semen Pharbitidis 2 parts.
The present invention, according to the etiology and pathogenesis of obesity, through research and experimental verification for many years, obtains this formula, each crude drug compatibility science in formula, collaborative onset, and when normal diet, energy quick weight-lossing, fine to bariatrician effect.Each crude drug effect is as follows:
Poria, property is flat, sweet in the mouth and, avirulence.Function benefiting vital QI for tranquillizing, invigorating the spleen and regulating the stomach, dispels damp and hot, row water stopping leak, the disease such as treatment deficiency of vital energy impairment caused by overstrain, trusted subordinate's distension, edema, diarrhoea, forgetful, insomnia.
The Rhizoma Pinelliae, has drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass, effect of reducing swelling and alleviating pain, controls damp-phlegm cold drink, vomiting, regurgitation, cough with asthma abundant expectoration, chest and diaphragm distension, and syncope due to accumulation of phlegm is had a headache, dizzy sleeplessness.
Rhizoma Atractylodis, nature and flavor are pungent, bitter, temperature.Have drying damp and strengthening spleen, effect of wind-damp dispelling, cures mainly retention of dampness in middle-JIAO, anemofrigid-damp arthralgia, foot swelling and pain in knee, and flaccidity is soft unable, nyctalopia nyctalopia.
Rhizoma Cyperi, the dry rhizome of sedge dried tuber, the pungent micro-hardship of nature and flavor, sweet, flat.Function is regulated the flow of vital energy resolving depression, and menstruction regulating and pain relieving is antiabortive.Main distending pain over the hypochondrium, mammary swelling is educated, hernia pain, menoxenia, gastral cavity abdomen feeling of fullness pain, belch acid regurgitation, vomiting and nausea, abdominal pain during menstruation, bleeding not during menses, frequent fetal movement.
Pericarpium Citri Reticulatae, the mature peel of rutaceae orange and variety thereof.Nature and flavor are bitter, pungent, temperature.There is regulating qi-flowing for strengthening spleen, effect of drying dampness to eliminate phlegm.For fullness in the epigastrium and chest, lack of appetite and vomiting, cough with copious phlegm.
Massa Medicata Fermentata, the medicines such as Herba polygoni hydropiperis, Herba Artemisiae Annuae, Semen Armeniacae Amarum add flour or wheat bran mixed after, through the herbal leaven of fermentation.Warm in nature, sweet in the mouth, pungent, nontoxic, there is effect of invigorating the spleen and regulating the stomach, promoting digestion and removing stagnation.Cure mainly the diseases such as retention of food and drink, dyspepsia, distension and fullness in the abdomen, inappetence, vomiting dysentery.
Rhizoma Chuanxiong, the rhizome of Umbelliferae Rhizoma Chuanxiong, nature and flavor are pungent, warm.Have blood-activating and qi-promoting, effect of wind-expelling pain-stopping, for menoxenia, amenorrhea dysmenorrhea, abdominal mass is suffered from abdominal pain, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.
Semen Pharbitidis, convolvulaceous plant pharbitis nilChoisy Pharbitis nil(L.) Choisy or Pharbitis purpurea Pharbitis purpurea(L.) dry mature seed of Voigt.Nature and flavor are bitter, cold, poisonous.Have removing water retention by purgation relieving constipation, drink is washed in expectorant, and parasite killing attacks long-pending effect, and for edema distension, constipation and anuresis, phlegm retention is gathered, and QI rising in reverse order is breathed with cough, abdominal pain due to worm stagnation, ascarid, taeniasis.
Compatibility science of the present invention, consumption is precise and appropriate, determined curative effect.Poria in side, the Rhizoma Pinelliae, Rhizoma Atractylodis, Pericarpium Citri Reticulatae spleen invigorating eliminate the phlegm removing dampness, Massa Medicata Fermentata strengthening the spleen and stomach removing food stagnancy is eaten, Rhizoma Cyperi depressed liver-energy dispersing and QI regulating and resolving depression, Rhizoma Chuanxiong, the blood stasis dispelling of Semen Pharbitidis blood-activating and qi-promoting, treating both the principal and secondary aspects of a disease is share in medicine-feeding, there is invigorating the spleen for dissipating phlegm, effect of resolving depression of regulating the flow of vital energy, blood circulation promoting and blood stasis dispelling, can very well treatment of obesity, without bounce-back.
On the basis of original formula, other crude drug can also be added, strengthen curative effect, such as can add Flos Granati further, Rhizoma Dioscoreae, Jujube Leaves, strengthen spleen invigorating, invigorate blood circulation, blood stasis dispelling effect, the crude drug formula formed is (weight portion): Poria 8-12 part, Rhizoma Pinelliae 8-15 part, Rhizoma Atractylodis 8-12 part, Rhizoma Cyperi 8-12 part, Pericarpium Citri Reticulatae 2-5 part, Massa Medicata Fermentata 8-15 part, Rhizoma Chuanxiong 8-12 part, Semen Pharbitidis 1-3 part, Flos Granati 1-2 part, Rhizoma Dioscoreae 5-10 divides, Jujube Leaves 1-3 part, be preferably (weight portion): 10 parts, Poria, the Rhizoma Pinelliae 10 parts, Rhizoma Atractylodis 10 parts, Rhizoma Cyperi 10 parts, Pericarpium Citri Reticulatae 3 parts, Massa Medicata Fermentata 10 parts, Rhizoma Chuanxiong 10 parts, Semen Pharbitidis 2 parts, Flos Granati 1.5 parts, Rhizoma Dioscoreae 8 parts, Jujube Leaves 2 parts.
Preparation method of the present invention is: dried by Flos Granati or dry (if any), mixes with other raw materials, decocts with water to make decoction and take, every day potion.Or Flos Granati dried or dries (if any), mixing with other raw materials, wear into fine powder, making powder and take, each 3-5 gram, every day 3 times.
Scientific formulation of the present invention, taking convenience, good absorbing, side effect is little, has invigorating the spleen for dissipating phlegm, effect of resolving depression of regulating the flow of vital energy, blood circulation promoting and blood stasis dispelling, can quick weight-lossing, rapid-action to obesity, without bounce-back, stable curative effect, definite.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, it is to be understood that following explanation is only to explain the present invention, do not limit its content.
embodiment 1
Crude drug formula of the present invention is: Poria 10g, Rhizoma Pinelliae 10g, Rhizoma Atractylodis 10g, Rhizoma Cyperi 10g, Pericarpium Citri Reticulatae 3g, Massa Medicata Fermentata 10g, Rhizoma Chuanxiong 10g, Semen Pharbitidis 2g.
Preparation method is: get above-mentioned raw materials, decocts with water, and makes decoction, every day potion.
embodiment 2
Crude drug formula of the present invention is: Poria 8g, Rhizoma Pinelliae 15g, Rhizoma Atractylodis 8g, Rhizoma Cyperi 12g, Pericarpium Citri Reticulatae 2g, Massa Medicata Fermentata 15g, Rhizoma Chuanxiong 8g, Semen Pharbitidis 3g.Preparation method is with embodiment 1.
embodiment 3
Crude drug formula of the present invention is: Poria 12g, Rhizoma Pinelliae 8g, Rhizoma Atractylodis 12g, Rhizoma Cyperi 8g, Pericarpium Citri Reticulatae 5g, Massa Medicata Fermentata 8g, Rhizoma Chuanxiong 12g, Semen Pharbitidis 1g.Preparation method is with embodiment 1.
embodiment 4
Crude drug formula of the present invention is: Poria 10g, Rhizoma Pinelliae 10g, Rhizoma Atractylodis 10g, Rhizoma Cyperi 10g, Pericarpium Citri Reticulatae 3g, Massa Medicata Fermentata 10g, Rhizoma Chuanxiong 10g, Semen Pharbitidis 2g, Flos Granati 1.5g, Rhizoma Dioscoreae 8g, Jujube Leaves 2g.
Preparation method is: by Flos Granati dry or dry, then mix with other raw materials, decoct with water, make decoction, every day potion.
embodiment 5
Crude drug formula of the present invention is: Poria 8g, Rhizoma Pinelliae 15g, Rhizoma Atractylodis 8g, Rhizoma Cyperi 12g, Pericarpium Citri Reticulatae 2g, Massa Medicata Fermentata 15g, Rhizoma Chuanxiong 8g, Semen Pharbitidis 3g, Flos Granati 1g, Rhizoma Dioscoreae 10g, Jujube Leaves 1g.Preparation method is with embodiment 4.
embodiment 6
Crude drug formula of the present invention is: Poria 12g, Rhizoma Pinelliae 8g, Rhizoma Atractylodis 12g, Rhizoma Cyperi 8g, Pericarpium Citri Reticulatae 5g, Massa Medicata Fermentata 8g, Rhizoma Chuanxiong 12g, Semen Pharbitidis 1g, Flos Granati 2g, Rhizoma Dioscoreae 5g, Jujube Leaves 3g.Preparation method is with embodiment 4.
Medicine of the present invention can quick weight-lossing, has good therapeutical effect, and does not rebound, Be very effective to obesity.Below by its drug effect of clinical trial certificate.
clinical trial
1,
physical data: according to the relevant criterion in " diagnosis of simple obesity and efficacy assessment standard ", screen 220 pure obesity patients, wherein Mild Obesity person 72 people, central obesity person 116 people, severe obesity 32 people, male 100, women 120, age 18-50 year, average 39.5 years old, course of disease 2-10.
2,
therapeutic Method: patient is equally divided into 4 groups, no difference of science of statistics between each group, each group patient takes food according to rational diet all under guidance, and carries out suitable motion.At the same time, each group takes the medicine of the embodiment of the present invention 1,2,4,5 respectively according to method of the present invention.
3,
criterion of therapeutical effect
Effective: weight recovery arm's length standard or weight loss ratio (at the end for the treatment of, weight loss numerical value accounts for the percentage ratio of the difference of ABW and standard body weight) >60%;
Effective: weight loss is than being 30-60%;
Invalid: weight loss is than below 30%.
4,
therapeutic outcome
Treat 2 courses for the treatment of (month being a course for the treatment of) according to the method described above, about 2 week of drug administration, there is decline phenomenon in most of weight in patients, and within about 1 month, decline obvious, after 2 months, therapeutic outcome is as follows:
Above-mentioned 220 patients adopt the medicine overwhelming majority of the present invention to show good effect, and rapid-action, and through further treating, weight in patients can be reduced to standard body weight substantially.The patient recovered after standard body weight cuts out medicine, within 2 years, pays a return visit afterwards without recurrence.In addition, during drug administration, all patients all have no adverse reaction, and illustrate that medicine of the present invention has no side effect substantially to human body.
Claims (4)
1. a Chinese medicine composition for treatment of obesity, is characterized in that: raw material medicaments in part by weight is counted: Poria 8-12 part, Rhizoma Pinelliae 8-15 part, Rhizoma Atractylodis 8-12 part, Rhizoma Cyperi 8-12 part, Pericarpium Citri Reticulatae 2-5 part, Massa Medicata Fermentata 8-15 part, Rhizoma Chuanxiong 8-12 part, Semen Pharbitidis 1-3 part.
2. Chinese medicine composition according to claim 1, is characterized in that: raw material medicaments in part by weight is counted: 10 parts, Poria, the Rhizoma Pinelliae 10 parts, Rhizoma Atractylodis 10 parts, Rhizoma Cyperi 10 parts, Pericarpium Citri Reticulatae 3 parts, Massa Medicata Fermentata 10 parts, Rhizoma Chuanxiong 10 parts, Semen Pharbitidis 2 parts.
3. the Chinese medicine composition of a treatment of obesity, it is characterized in that: raw material medicaments in part by weight is counted: Poria 8-12 part, Rhizoma Pinelliae 8-15 part, Rhizoma Atractylodis 8-12 part, Rhizoma Cyperi 8-12 part, Pericarpium Citri Reticulatae 2-5 part, Massa Medicata Fermentata 8-15 part, Rhizoma Chuanxiong 8-12 part, Semen Pharbitidis 1-3 part, Flos Granati 1-2 part, Rhizoma Dioscoreae 5-10 part, Jujube Leaves 1-3 part.
4. Chinese medicine composition according to claim 3, is characterized in that: raw material medicaments in part by weight is counted: 10 parts, Poria, the Rhizoma Pinelliae 10 parts, Rhizoma Atractylodis 10 parts, Rhizoma Cyperi 10 parts, Pericarpium Citri Reticulatae 3 parts, Massa Medicata Fermentata 10 parts, Rhizoma Chuanxiong 10 parts, Semen Pharbitidis 2 parts, Flos Granati 1.5 parts, Rhizoma Dioscoreae 8 parts, Jujube Leaves 2 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410007923.XA CN103735778B (en) | 2014-01-08 | 2014-01-08 | A kind of Chinese medicine composition for the treatment of of obesity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410007923.XA CN103735778B (en) | 2014-01-08 | 2014-01-08 | A kind of Chinese medicine composition for the treatment of of obesity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103735778A CN103735778A (en) | 2014-04-23 |
| CN103735778B true CN103735778B (en) | 2015-10-28 |
Family
ID=50492894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410007923.XA Expired - Fee Related CN103735778B (en) | 2014-01-08 | 2014-01-08 | A kind of Chinese medicine composition for the treatment of of obesity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103735778B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343824A (en) * | 2015-11-24 | 2016-02-24 | 青岛麦瑞特医药技术有限公司 | Traditional Chinese medicine composition for treating childhood obesity and preparation method thereof |
-
2014
- 2014-01-08 CN CN201410007923.XA patent/CN103735778B/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 减肥丸治疗肥胖症186例;刘锁超;《陕西中医》;20030925;第24卷(第9期);787-788 * |
| 加味茯苓汤治疗儿童期单纯性肥胖症22例疗效观察;黄莉萍 等;《中医儿科杂志》;20080115;第4卷(第1期);36-37 * |
| 漫谈肥胖病及中医的治疗;哈孝贤;《开卷有益.求医问药》;20020602(第6期);36-37 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103735778A (en) | 2014-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178912B (en) | Chinese medicine preparation for relieving gastral cavity crymodynia symptoms of people with yang deficiency as well as preparation method and application thereof | |
| CN101947304A (en) | Traditional Chinese medicinal composition for treating cold gastroenteropathy | |
| CN104784673B (en) | A kind of Chinese traditional medicine navel for infantile diarrhea pastes | |
| CN101518594A (en) | Anti-tumor immunity-enhancing traditional Chinese medicine preparation and preparation method thereof | |
| CN105816802A (en) | Orally-taken traditional Chinese medicine preparation for treating wind heat-type common cold | |
| CN102178866B (en) | Chinese medicinal preparation for dispelling damp, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and blood-stagnation physique, preparation method thereof and application thereof | |
| CN105381424A (en) | Traditional Chinese medicine for detoxifying human viscera and preparation method of traditional Chinese medicine | |
| CN104815232A (en) | Traditional Chinese medicine preparation for treating primary pulmonary hypertension and preparation method thereof | |
| CN106039196B (en) | A pharmaceutical composition for treating hyperlipidemia | |
| CN103735778B (en) | A kind of Chinese medicine composition for the treatment of of obesity | |
| CN104398733A (en) | Traditional Chinese medicine preparation for treating liver depression and qi stagnation type thyroid cancer | |
| CN104740288A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN103520673B (en) | Traditional Chinese medicine for treating deficiency of Qi and blood syndrome type of menopathy | |
| CN105381441A (en) | Traditional Chinese medicine capsule for preventing and treating cyesedema and preparation method of traditional Chinese medicine capsule | |
| CN105250961A (en) | Medicine for treating hyperplasia of mammary glands | |
| CN104127753A (en) | Traditional Chinese medicine tea bag for treating gouty arthritis and preparation method thereof | |
| CN103877484A (en) | Traditional Chinese medicine oral liquid for treating oral liquid | |
| CN103127427A (en) | Chinese medicinal composition for treating chronic pelvic inflammation | |
| CN105920302A (en) | Traditional Chinese medicine composition for treating gallstone | |
| CN105456951A (en) | Traditional Chinese medicine preparation for treating breast fibroadenoma and preparing method of traditional Chinese medicine preparation | |
| CN105250816A (en) | Medicine composition for treating phlegmatic hygrosis and preparation method and application of medicine composition | |
| CN105796815A (en) | Kidney-reinforcing and bone-strengthening liquor and preparation method thereof | |
| CN105232868A (en) | Traditional Chinese medicine combination treating muscle and bone injury pain | |
| CN105288422A (en) | Traditional Chinese medicine preparation used for treating eilema syndromes and preparation method | |
| CN104324252A (en) | Traditional Chinese medicine preparation for treating sudden dizziness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG BENDONG Free format text: FORMER OWNER: WEI SHAOLIANG Effective date: 20150828 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Bendong Inventor before: Wu Lianhe Inventor before: Wei Shaoliang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WU LIANHE WEI SHAOLIANG TO: WANG BENDONG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150828 Address after: Yimin 256100 Shandong city of Zibo province Yiyuan County Road No. 1 Applicant after: Wang Bendong Address before: 272037 Jining City Hospital of traditional Chinese medicine, 3 Ring Road North, Jining, Shandong Applicant before: Wei Shaoliang |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151028 Termination date: 20170108 |